Ziyuan Shen

5PUBLICATIONS
31CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 22, 2026
Long-term follow-up of third generation anti-CD30 CAR T-cell therapy in relapsed/refractory CD30+ lymphomas: a single-arm, multicentre, phase 1-2 trial.

|Mar 06, 2026
Genetic Evidence Reveals Causal Effect of Circulating Proteome on Random Glucose: A Mendelian Randomization Study.

Ziyuan Shen, Xing Xing, Xiaoyue Zhang

|Aug 23, 2025
Prognostic value of the co-stimulatory molecule OX40 expression in Extranodal Natural Killer/T-cell Lymphoma.

Haiyan Zhang, Yujie Li, Qing Zhang

|Jul 23, 2024
A novel prognostic index for extranodal natural killer/T-cell lymphoma in the era of pegaspargase/L-asparaginase.

Ziyuan Shen, Xudong Zhang, Yujie Li

|Oct 30, 2023
Comparative analysis of clinicopathologic characteristics and prognosis between nasal and nonnasal extranodal NK/T-cell lymphoma.

Ziyuan Shen, Xicheng Chen, Cai Sun

Pageof 1

Frequent Collaborators

3 joint publications

Wei Sang

2 joint publications

Guoqi Cai

1 joint publications

Liang Wang

1 joint publications

Xing Xing